Filter News
Area of Research
- Advanced Manufacturing (1)
- Biological Systems (1)
- Biology and Environment (20)
- Clean Energy (9)
- Computational Biology (2)
- Computational Engineering (1)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (24)
- Fusion Energy (13)
- Isotopes (5)
- Materials (17)
- Materials for Computing (2)
- National Security (4)
- Neutron Science (13)
- Nuclear Science and Technology (10)
- Supercomputing (45)
News Topics
- (-) Biomedical (58)
- (-) Frontier (42)
- (-) Fusion (54)
- 3-D Printing/Advanced Manufacturing (121)
- Advanced Reactors (34)
- Artificial Intelligence (91)
- Big Data (53)
- Bioenergy (91)
- Biology (98)
- Biotechnology (22)
- Buildings (57)
- Chemical Sciences (63)
- Clean Water (29)
- Climate Change (99)
- Composites (26)
- Computer Science (187)
- Coronavirus (46)
- Critical Materials (26)
- Cybersecurity (35)
- Decarbonization (79)
- Education (4)
- Element Discovery (1)
- Emergency (2)
- Energy Storage (108)
- Environment (194)
- Exascale Computing (37)
- Fossil Energy (5)
- Grid (62)
- High-Performance Computing (84)
- Hydropower (11)
- Irradiation (3)
- Isotopes (53)
- ITER (7)
- Machine Learning (47)
- Materials (144)
- Materials Science (140)
- Mathematics (7)
- Mercury (12)
- Microelectronics (3)
- Microscopy (51)
- Molten Salt (8)
- Nanotechnology (60)
- National Security (61)
- Net Zero (13)
- Neutron Science (131)
- Nuclear Energy (108)
- Partnerships (44)
- Physics (61)
- Polymers (33)
- Quantum Computing (34)
- Quantum Science (69)
- Renewable Energy (2)
- Security (24)
- Simulation (47)
- Software (1)
- Space Exploration (25)
- Statistics (3)
- Summit (57)
- Sustainable Energy (125)
- Transformational Challenge Reactor (7)
- Transportation (97)
Media Contacts
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
From the helm of a one-of-a-kind organization that brings nuclear fusion and fission expertise together to pave the way to expanding carbon-free energy, Kathy McCarthy can trace the first step of her engineering career back to
Thirty-two Oak Ridge National Laboratory employees were named among teams recognized by former DOE Secretary Dan Brouillette with Secretary’s Honor Awards as he completed his term. Four teams received new awards that reflect DOE responses to the coronavirus pandemic.
The INFUSE fusion program announced a second round of 2020 public-private partnership awards to accelerate fusion energy development.
Oak Ridge National Laboratory and collaborators have discovered that signaling molecules known to trigger symbiosis between plants and soil bacteria are also used by almost all fungi as chemical signals to communicate with each other.
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
Chuck Kessel was still in high school when he saw a scientist hold up a tiny vial of water and say, “This could fuel a house for a whole year.”
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
Scientists from Oak Ridge National Laboratory used high-performance computing to create protein models that helped reveal how the outer membrane is tethered to the cell membrane in certain bacteria.